Logo Logo

Publications by Kahnert, K.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 4.

Journal article

Kauffmann-Guerrero, D.; Kahnert, K.; Reu, S.; Jung, A.; Synyaeva, Z.; Mertsch, P.; Huber, R. M. (2017): NSCLC patients harbouring a rare or complex EGFR mutation are more often smokers and might not benefit from first line TKI therapy. In: Annals of Oncology, Vol. 28

Kahnert, K.; Lucke, T.; Biertz, F.; Lechner, A.; Alter, P.; Bals, R.; Watz, H.; Behr, Jürgen; Holle, R.; Huber, R. M.; Karrasch, S.; Stubbe, B.; Wacker, M.; Sohler, S.; Wouters, E. F. M.; Vogelmeier, C.; Jorres, R. (2017): Transfer Factor For Carbon Monoxide In Patients With COPD And Diabetes: Results From The German Cosyconet Cohort. In: American Journal of Respiratory and Critical Care Medicine, Vol. 195

Tufman, A.; Schirmer, U.; Kahnert, K.; Kiefl, R.; Kuner, R.; Mertsch, P.; Schröder, L.; Sültmann, H.; Huber, R. (2016): microRNA-Profi le in bronchialen Lavageproben von zwei Patientenkohorten: Korrelation mit Art der Erkrankung sowie lokale Zellexpression und Inflammation. In: Internist, Vol. 57: S49-S50

Huber, R. M.; Kahnert, K.; Syunyaeva, Z.; Mertsch, P. (2016): Bronchoscopic management Of a Pulmonary Tumorcavity After First-Line Therapy With Afatinib. In: American Journal of Respiratory and Critical Care Medicine, Vol. 193

This list was generated on Sat Aug 15 02:07:43 2020 CEST.